Results 221 to 230 of about 206,955 (264)
Some of the next articles are maybe not open access.
Carcinoma in situ of the Cornea
Ophthalmologica, 2010Carcinoma in situ of the cornea is part of a pathological entity, which covers all conjunctival and corneal epithelial neoplasiae (CIN). The clinicopathological characteristics of this rare ocular tumor will be demonstrated.
U, Steinhorst, D, von Domarus
openaire +2 more sources
Endocrine Practice, 2013
Pituitary carcinomas are extremely rare tumors associated with poor prognosis despite surgery, radiation, and chemotherapy. The hallmark of diagnosis implies subarachnoid, brain, or systemic tumor spread.We report a case of rapid transformation of atypical nonfunctioning pituitary adenoma to a carcinoma.A 64-year-old woman presented with sudden onset ...
Francisco J, Pasquel +4 more
openaire +2 more sources
Pituitary carcinomas are extremely rare tumors associated with poor prognosis despite surgery, radiation, and chemotherapy. The hallmark of diagnosis implies subarachnoid, brain, or systemic tumor spread.We report a case of rapid transformation of atypical nonfunctioning pituitary adenoma to a carcinoma.A 64-year-old woman presented with sudden onset ...
Francisco J, Pasquel +4 more
openaire +2 more sources
Breast Disease, 2001
Ductal carcinoma in situ (DCIS) has become a predominant pathologic entity with the broad implementation of screening mammography. In the premammographic era, it represented less than 10% of all breast cancers. Although it now occupies as much as 30% of contemporary series, it remains a controversial subject of debate in terms of its management.
openaire +2 more sources
Ductal carcinoma in situ (DCIS) has become a predominant pathologic entity with the broad implementation of screening mammography. In the premammographic era, it represented less than 10% of all breast cancers. Although it now occupies as much as 30% of contemporary series, it remains a controversial subject of debate in terms of its management.
openaire +2 more sources
Carcinoma in Situ of the Testis
Journal of Urology, 1989Analyse de l'histologie, de la frequence, de l'evolution naturelle, du diagnostic, du traitement et de la signification etiopathogenique possible du cancer in ...
Y, Reinberg, J C, Manivel, E E, Fraley
openaire +2 more sources
Oral Surgery, Oral Medicine, Oral Pathology, 1975
Oral carcinoma in situ (CIS) as a histopathologic entity was studied in seventy-seven patients to determine the clinical and histologic parameters of the disease. There were forty-nine male and twenty-eight female patients, with 45.1 per cent of the lesions being described clinically as white, 15.9 per cent as red, and 8.5 per cent as a combination of ...
C A, Waldron, W G, Shafer
openaire +2 more sources
Oral carcinoma in situ (CIS) as a histopathologic entity was studied in seventy-seven patients to determine the clinical and histologic parameters of the disease. There were forty-nine male and twenty-eight female patients, with 45.1 per cent of the lesions being described clinically as white, 15.9 per cent as red, and 8.5 per cent as a combination of ...
C A, Waldron, W G, Shafer
openaire +2 more sources
Carcinoma In Situ of the Breast
Surgical Clinics of North America, 1971The combination of mammography with biopsy of lesions suspicious either radiographically or on physical examination has afforded greater insight as to the frequency and significance of carcinoma in situ. The characteristics of lobular and intraductal carcinomas are discussed, and a question is raised whether chronic cystic mastitis should be considered
openaire +2 more sources
Carcinoma of the Bladder In Situ
JAMA: The Journal of the American Medical Association, 1969To the Editor:— In a recent summary article on cancer of the urinary bladder (206:1761, 1968) there is a total absence of information on some of the newer developments in the understanding of the natural history of this disease. The concepts of carcinoma in situ of the bladder and the cytologic diagnosis of bladder cancer during the preclinical stages
openaire +2 more sources

